Remaining on guard for fraud in a time of crisis
As government agencies rapidly respond to COVID-19, they may also experience shifts in claims patterns and increased potential for fraud, waste and abuse.
Why healthcare payers should consider re-thinking how they manage patient consent
When it comes to consent management, healthcare payers can potentially use this period of disruption...
3 considerations for employment agencies during the public health and economic crisis
Authors: David Nelson & Andreas Gollner
How to make the most of disruption
Re-thinking their approaches during this time of change can help leaders in healthcare, life sciences and government to innovate and enable their organizations to emerge stronger than ever.
Integrating AI-powered clinical decision support into the EHR can help increase adoption and efficiency
Clinical decision support tools offer clinicians the ability to enhance the quality of care given to...
What patient-reported data can tell us about how to improve medication adherence
In a recent PULSE Health Poll, patients share why they do (and don’t) take prescriptions, which ...
Research reveals practice patterns in precision oncology
A new study of a cohort of Veterans Health Affairs (VHA) oncology patients illustrates complexity of clinician decision making around targeted therapies in a fast-moving field
Eliminating bias in health data science
It’s time for a renewed commitment to fairness, transparency and equity in data, big data and the algorithms for statistical or artificial intelligence (AI) models
Q&A: Interoperability and COVID-19, Part 2
Dr. Anil Jain describes how the pandemic’s disruption may affect the trajectory of sharing health information and considerations for those healthcare providers looking to invest.
A call for more complete race and ethnicity health data for COVID-19 response
Reported race and ethnicity health data is incomplete, with only 40 out of 50 states including this ...
Q&A: Interoperability and COVID-19, Part 1
How the pandemic response intersects with interoperability and requires healthcare providers to decide if they will defer or double-down on interoperability efforts.
How Long Will a Vaccine Really Take?
A vaccine would be the ultimate weapon against the coronavirus and the best route back to normal life.
The need to flatten the 4 curves of COVID-19
Responding to the pandemic requires us to “flatten the curve” that traces the physical impact of the disease. That's just the first curve. Additional curves are ascending for chronic disease management, mental health and economic health.
COVID-19’s watershed moment for radiology
David Gruen, MD, MBA, FACR
6 capabilities that can help U.S. healthcare payers make progress toward interoperability
With soaring demand for social services, field-tested technology can help governments scale up
The 5 V’s of big data
by Anil Jain, MD, FACP
Telehealth emerges as critical weapon for public health ...
by Peggy O'Brien
Examining the variation in cancer care
by Watson Health